AVANZ Salsola

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Allergic Rhinoconjunctivitis Due to Salsola Kali Pollen

Drug Information

Target Indication

Allergic Rhinoconjunctivitis Due to Salsola Kali Pollen

Clinical Trial

Last updated: 6/28/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

ALK-B.CO

ALK-Abelló A/S

Related Pipeline

Allergic Rhinoconjunctivitis

Allergy

Asthma

Allergic Rhinitis Due to Dermatophagoides Farinae

Rhinitis Allergic

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts